DoctorsProofNPPES directory · verify at state boards

Pulmonary Disease in Roseville, MI

4 verified pulmonary disease doctors in Roseville.

Pulmonologists diagnose and treat diseases of the lungs and respiratory system, such as asthma, COPD, and sleep apnea.

NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.

Verify a license at the Michigan Board of Medicine

Dr. Robert Marchese, MD

Pulmonary Disease

20 yrs NPPES
NPI 1043290232
25810 KELLY RD, SUITE 3, Roseville, MI 48066(586) 777-9724
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. William Hanna, MD

Pulmonary Disease

20 yrs NPPES
NPI 1740246222
25990 KELLY RD STE 4, Roseville, MI 48066(586) 774-3780
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Emad Alatassi, MD

Pulmonary Disease

20 yrs NPPES
NPI 1528018256
18263 E 10 MILE RD STE D, Roseville, MI 48066(586) 238-2060
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,747 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,747

Total received

63

Transactions

16

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$584.68
AstraZeneca Pharmaceuticals LP$284.22
Genzyme Corporation$212.03
Mylan Specialty L.P.$184.21
sanofi-aventis U.S. LLC$99.95
Inogen, Inc.$65.74

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 85th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Emad Alatassi do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Fadi-Jean Saad, MD

Pulmonary Disease

20 yrs NPPES
NPI 1174573810
18263 E 10 MILE RD, SUITE D, Roseville, MI 48066(586) 778-3478
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $329.26 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$329.26

Total received

23

Transactions

10

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$127.00
Regeneron Healthcare Solutions, Inc.$48.49
Genzyme Corporation$37.02
Medtronic, Inc.$23.31
Takeda Pharmaceuticals U.S.A., Inc.$20.56
Jazz Pharmaceuticals Inc.$15.10

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 70th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Fadi-Jean Saad do not imply any wrongdoing. Many are meals, education, or research support.

Pulmonary Disease in Roseville, MI — Verified | DoctorsProof | DoctorsProof